Effect of Low-Immunogenic Yogurt Drinks and Probiotic Bacteria on Immunoreactivity of Cow’s Milk Proteins and Tolerance Induction—In Vitro and In Vivo Studies

Autor: Ewa Fuc, Barbara Wróblewska, Anna Maria Ogrodowczyk, Ewa Wasilewska, Lidia Hanna Markiewicz, Dagmara Złotkowska, Anna Kaliszewska-Suchodoła
Rok vydání: 2020
Předmět:
Zdroj: Nutrients
Volume 12
Issue 11
ISSN: 2072-6643
DOI: 10.3390/nu12113390
Popis: There is no effective therapy for milk allergy. The role of lactic acid bacteria (LAB) and probiotics in protection against allergy-related outcomes is still under investigation. The aim of the study was to evaluate the immunomodulative and therapeutic potential of yogurt drinks in cow&rsquo
s milk allergy (CMA) management. We compared immunoreactivity of &alpha
casein (&alpha
CN), &beta
casein (&beta
CN), &kappa
casein (&kappa
CN), &alpha
lactalbumin (&alpha
LA), and &beta
lactoglobulin (&beta
LG) in 27 yogurt drinks fermented with different basic yogurt cultures, or yogurt cultures enriched with Lactobacillus plantarum and/or Bifidobacterium lactis strains, by competitive ELISA assay. Drinks with the lowest antigenic potential were used as allergoids for CMA therapy. BALB/c mice were sensitized via intraperitoneal injection of &alpha
CN + &beta
LG mixture with aluminum adjuvant, and gavaged with increasing doses of selected low-immunogenic drinks (YM&mdash
basic, or YM-LB&mdash
enriched with L. plantarum and B. lactis) to induce tolerance. Milk- or phosphate-buffered saline (PBS)-dosed mice served as controls. Compared to milk, the immunoreactivity of proteins in drinks increased or decreased, depending on the bacterial sets applied for fermentation. Only a few sets acted synergistically in reducing immunoreactivity. The selected low-immunogenic drinks stimulated allergic mice for profiling Th2 to Th1 response and acquire tolerance, and the effect was greater with YM-LB drink, which during long-lasting interventional feeding strongly increased the secretion of regulatory cytokines, i.e., IL-10 and TGF-&beta
and IgA and decreased IL-4, IgE, and anti-(&alpha
LG) IgG1. The studies revealed variations in the potency of yogurt bacteria to change allergenicity of milk proteins and the need for their strict selection to obtain a safe product for allergy sufferers. The YM-LB drink with reduced antigenic potential may be a source of allergoids used in the immunotherapy of IgE mediated CMA, but further clinical or volunteer studies are required.
Databáze: OpenAIRE